US Patent Issued to SHIONOGI & Co., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY on Feb. 24 for "Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,474, issued on Feb. 24, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan) and NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (Hokkaido, Japan).

"Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same" was invented by Yuki Tachibana (Osaka, Japan), Shota Uehara (Osaka, Japan), Yuto Unoh (Osaka, Japan), Kenji Nakahara (Osaka, Japan), Yoshiyuki Taoda (Osaka, Japan), Koji Kasamatsu (Osaka, Japan), Yukiko Yamatsu (Osaka, Japan), Shigeru Ando (Osaka, Japan), Takahiro Suto (Osaka, Japan) and Michihito Sasaki (Sapporo, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound represen...